Pharmacokinetics of antifungal medications are considered inherently more unpredictable than most antibacterials.

This project will link our international collaborators to generate new knowledge on the adequacy of current antifungal dosing (caspofungin, micafungin, anidulafungin, voriconazole, itraconazole, posaconazole, fluconazole) in a large cohort of ICU patients from over a 6-month patient enrolment period.